Anthem (ANTM) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to Anthem (ANTM) Tops Q4 EPS by 2c
February 1, 2018 8:44 AM EST
Credit Suisse raised its price target on Anthem (NYSE: ANTM) to $280.00 (from $255.00) while maintaining a Outperform rating.
...
More
February 1, 2018 7:38 AM EST
Morgan Stanley raised its price target on Anthem (NYSE: ANTM) to $266.00 (from $247.00) while maintaining a Equalweight rating.
...
More
February 1, 2018 6:40 AM EST
Piper Jaffray raised its price target on Anthem (NYSE: ANTM) to $278.00 (from $260.00) while maintaining a Overweight rating.
...
More
February 1, 2018 5:21 AM EST
Citi raised its price target on Anthem (NYSE: ANTM) to $286.00 (from $236.00) while maintaining a Buy rating.
...
More
January 31, 2018 6:07 AM EST
Anthem, Inc. (NYSE: ANTM) announced today that Bahija Jallal, PhD, has been named to its Board of Directors effective February 1, 2018.
With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Jallals science-driven leadership combined with her passion to improve the lives of patients will be an asset to Anthems Board as they guide the Company... More
January 31, 2018 6:06 AM EST
Anthem (NYSE: ANTM) declared a quarterly dividend of $0.75 per share, or $3 annualized. This is a 7.1% increase from the prior dividend of $0.70.
The dividend will be payable on March 23, 2018, to stockholders of record on March 9, 2018, with an ex-dividend date of March 8,... More
